Stocks
BridgeBio Pharma, Inc.BBIO
NASDAQHealthcareBiotechnology$69.41+2.10%
Focused on developing therapies for genetic diseases, the company operates a network of subsidiary programs that advance drug candidates from early research through late-stage clinical development. Its pipeline includes treatments targeting rare cardiovascular, dermatologic, and metabolic disorders,...
Market Cap: $13.5B52W Range: $28.32 – $84.94
Congressional Interest in BridgeBio Pharma, Inc. (BBIO)
2 members of Congress have disclosed 6 trades in BridgeBio Pharma, Inc. (BBIO), a Healthcare company. The buy/sell breakdown shows 6 purchases versus 0 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
6
Unique Politicians
2
Buys
6
Sells
0
Who in Congress Is Trading BBIO?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2026-03-19 | Gilbert Cisneros | buy | $1K – $15K |
| 2026-03-18 | Gilbert Cisneros | buy | $1K – $15K |